Related Experiment Video
Updated: May 2, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Development, formulation, and characterization of an adapalene-loaded solid lipid microparticle dispersion for
Andreas Lauterbach1, Christel C Mueller-Goymann1
1Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Mendelssohnstraße 1, Braunschweig 38106, Germany.
Abstract:
The model retinoid adapalene was formulated in a novel solid lipid microparticle (SLM) dispersion as a topical drug delivery system for transport of the active pharmaceutical ingredient (API) into hair follicle orifices. The aims of the investigations were the solid-state characterization of the lipid matrix (LM) with wide angle X-ray diffraction (WAXD) and hot-stage light microscopy (HS), the design space analysis of the developed SLM dispersion with a Box-Behnken design, the stability study of the manufactured formulation for particle size with laser diffraction and polarization intensity differential scattering (LD/PIDS) and thermal behavior with differential scanning calorimetry (DSC), and the structure analysis of the SLM dispersion with light microscopy, transmission electron microscopy (TEM), and scanning electron microscopy (SEM). The formulation showed a constant mean particle size (MPS) of 4.2 μm over 24 weeks with a melting point of about 56°C. The potential for dermal application was determined by a follicular penetration (FP) study with porcine ear skin and thermal analysis of the interaction with artificial human skin lipids like sebum and stratum corneum lipid mixture. The in vitro studies confirmed both the follicular penetration potential and a targeted erosion or dissolution of the particles in sebum.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Influencing Drug Absorption: Drug Dissolution
Bioavailability Enhancement: Drug Solubility Enhancement
Modified-Release Drug Delivery Systems: Site-Targeted
Ophthalmic Drug Delivery Systems

